Bersamin’s name popped up when former DPWH undersecretary Roberto Bernardo claimed meeting with Department of Education (DepEd) Undersecretary Trygve Olaivar to discuss “Unprogrammed Appropriations ...
MiNK Therapeutics, Inc. (Nasdaq: INKT), a clinical-stage biopharmaceutical company pioneering invariant natural killer T (iNKT) cell therapies, today announced that its President and Chief Executive ...
CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) ('Plus” or the 'Company”), announced today that it has signed a national agreement with UnitedHealthcare ...
Annovis Bio, Inc. (NYSE: ANVS) ('Annovis' or the 'Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease ...
Dynacor Group Inc. (TSX: DNG) ('Dynacor' or the 'Corporation') announced its monthly dividend payment for October 2025 in the amount of C$0.01333 per common share which will be payable on October 16, ...
With this approval, NexoBrid is now authorized in 45 countries worldwide, reflecting its growing recognition as a new standard of care in burn management. MediWound’s exclusive partner in Australia, ...
Mid-Autumn Festival at Gardens by the Bay welcomed a creative Lantern show from the classic Chinese brand White Rabbit- 'Dancing of Butterflies.” The lantern transforms the shape of beloved White ...
The series features "Eyes,” a song by global K-pop sensation Tomorrow X Together (TXT). The song, which will be featured during the end credits of the series and in two of the episodes, originally ...
With effect from 1 October 2025, the coupon rate of the following bonds financing RD Euribor3®, RD Stibor3®, RD Stibor3® Green, RD Nibor3®, RD Cibor6® (RO), FlexGaranti® and RenteDyk® will be adjusted ...
HEFEI, CHINA - Media OutReach Newswire - 25 September 2025 - The 2025 World Manufacturing Convention, themed 'Intelligent Manufacturing for a Better Future,' concluded in Hefei. Over four days, the ...
Peer-reviewed results from Phase 1b/2a Trial of Anti-pTau Active Immunotherapy from AC Immune Published in eBioMedicine ...
Algernon Pharmaceuticals Inc. (the 'Company” or 'Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company announces that it has signed a definitive equipment order and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback